Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-07

FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (TruPharma LLC)

View source ↗

Summary

FDA approved a supplemental application for Bisoprolol Fumarate from TruPharma LLC, validating the generic product under ANDA075643.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol Fumarate (bisoprolol fumarate)

Snippet

SUPPL AP for BISOPROLOL FUMARATE (BISOPROLOL FUMARATE)